SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Vinnie Sebastian who wrote (12)9/12/1996 2:24:00 AM
From: Carlos Fung   of 1510
 
Vinnie,

I think this news will push IMNR higher in the short-term. If you want to buy some shares, now will be a good time and then sell them in a week or so since the stock seems, lately, to go up on good news but eventually starts to dip down on no further news and stay around $8-$10. If you can get some shares below $8, I would buy some and save them in case they will go up in the future. But to make a short-term profit, I think the stock will go up in the next couple of days. I like that IMNR is more active in their testing of products, but they always seem to be in Phase I and Phase II, occassionally they are in Phase III. Good luck, Carlos
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News